Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
February 2016 onwards
Submit An Event
Events - May 2014
High Content Analysis
14 May 2014 - 15 May 2014 - Barcelona, Spain
SELECTBIO is pleased to present the 11th High Content Analysis conference, which will take place at the Fira Barcelona, on May 14th & 15th 2014. Featuring an array of leading international speakers, this event aims to provide you with an insight into the latest developments in high content technologies and their applications.
Hot topics to be covered include novel 3D cell based screening methods, the use of model organisms, and live cell imaging approaches. Focus will also be given to the evolving use of microfluidics in this field. Attending this event will provide you with excellent opportunities for networking with like-minded peers, helping you to find solutions and build collaborations.
Anthony Davies, Director, High Content Research Facility, National Center for High Content Screening and Analysis (INCHA)
Hakim Djaballah, Director, Memorial Sloan Kettering Cancer Center
Running alongside the High Content Analysis conference will be the ELA exhibition, covering the latest technological advances and associated services from leading solution providers within this field. Registered delegates will also have access to the following co-located conference tracks, ensuring a cost effective trip:
Advances in qPCR & dPCR
Advances in NGS & Big Data
, Advances in Automation & Robotics and
Advances in Cellular Assays & Cell Culture
You can present your research on a poster while attending the meeting.
Deadline: 02 May 2014
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,500+ scientific and medical posters
3,800+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FREE!